About Chrono Therapeutics
Chrono Therapeutics is a company based in Waltham (United States) founded in 2004. It operates as a B2B. Chrono Therapeutics has raised $82.2 million across 8 funding rounds from investors including General Electric, HHS and Canaan. Chrono Therapeutics operates in a competitive market with competitors including Welldoc, DarioHealth, Wellthy Therapeutics, Valeritas and scPharmaceuticals, among others.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chrono Therapeutics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$82.2 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
General Electric
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chrono Therapeutics
Chrono Therapeutics has successfully raised a total of $82.2M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chrono Therapeutics
Chrono Therapeutics has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include General Electric, HHS and Canaan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated by Mayo Clinic Business Accelerator.
|
Locked | Locked | Locked | |
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Locked | Locked | Locked |
Investor details for Chrono Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chrono Therapeutics
Investment portfolio details for Chrono Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chrono Therapeutics
Detailed financials for Chrono Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chrono Therapeutics Comparisons
Peer comparison for Chrono Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chrono Therapeutics
Chrono Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welldoc, DarioHealth, Wellthy Therapeutics, Valeritas and scPharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile health products for chronic disease management are offered.
|
|
| Locked | Locked | Locked |
Chronic conditions are managed via a personalized digital platform.
|
|
| Locked | Locked | Locked |
Health monitoring app is provided for chronic patients and providers.
|
|
| Locked | Locked | Locked |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| Locked | Locked | Locked |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| Locked | Locked | Locked |
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
|
Detailed competitors of Chrono Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chrono Therapeutics
Complete news archive for Chrono Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chrono Therapeutics
Chrono Therapeutics was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Chrono Therapeutics is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Chrono Therapeutics is a funded company, having raised a total of $82.2M across 8 funding rounds to date.
Chrono Therapeutics, based in Waltham, focuses on providing healthcare solutions, developing medical devices, therapeutics, and smoking cessation. Develops transdermal nicotine replacement therapy for smoking cessation. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Chrono Therapeutics's top competitors include Welldoc, scPharmaceuticals and Wellthy Therapeutics.
Chrono Therapeutics has 17 investors. Key investors include General Electric, HHS, Canaan, National Cancer Institute, and Mayo Clinic Business Accelerator.